Found: 466
Select item for more details and to access through your institution.
In Vitro and in Silico Analysis of α -Amylase Inhibitory Activity of Ethanolic Extract of Adhatoda vasica Leaves.
- Published in:
- Global Advances in Integrative Medicine & Health, 2024, p. 1, doi. 10.1177/27536130241270621
- By:
- Publication type:
- Article
Commentary on 'Exploration of suitable pharmacodynamic parameters for acarbose bioequivalence evaluation: A series of clinical trials with branded acarbose' by Jie Huang et al.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 9, p. 2320, doi. 10.1111/bcp.16148
- By:
- Publication type:
- Article
Managing problems with medications for type 2 diabetes.
- Published in:
- Practice Nursing, 2017, v. 28, n. 4, p. 148, doi. 10.12968/pnur.2017.28.4.148
- By:
- Publication type:
- Article
The effect of additional acarbose on metformin-associated artificially high <sup>18</sup>F-Fluorodeoxyglucose uptake in positron emission tomography/computed tomography.
- Published in:
- Acta Diabetologica, 2022, v. 59, n. 7, p. 929, doi. 10.1007/s00592-022-01890-3
- By:
- Publication type:
- Article
Comparison of insulin monotherapy and combination therapy with insulin and metformin or insulin and rosiglitazone or insulin and acarbose in type 2 diabetes.
- Published in:
- Acta Diabetologica, 2007, v. 44, n. 4, p. 187, doi. 10.1007/s00592-007-0004-9
- By:
- Publication type:
- Article
In vitro studies on the antidiabetic and antibacterial activity of biosynthesized silver nanoparticles with aqueous extract of Moringa oleifera leaf.
- Published in:
- Journal of Pharmacy & Bioresources, 2024, v. 21, n. 1, p. 5, doi. 10.4314/jpb.v21i1.2
- By:
- Publication type:
- Article
Long-term administration of the α-amylase inhibitor acarbose effective against type 2 diabetes symptoms in C57BL/6 mice.
- Published in:
- Research Results in Pharmacology, 2024, v. 10, n. 2, p. 65, doi. 10.18413/rrpharmacology.10.455
- By:
- Publication type:
- Article
Early or late-life treatment with acarbose or rapamycin improves physical performance and affects cardiac structure in aging mice.
- Published in:
- Journals of Gerontology Series A: Biological Sciences & Medical Sciences, 2023, v. 78, n. 3, p. 397, doi. 10.1093/gerona/glac221
- By:
- Publication type:
- Article
Sex-dependent Differences in Liver and Gut Metabolomic Profiles With Acarbose and Calorie Restriction in C57BL/6 Mice.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Strategies and Challenges in Clinical Trials Targeting Human Aging.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Effect of Acarbose and olive leaf extract (Oleuropein) on Glycemic index and Antioxidant Status in High Fructose and H<sub>2</sub>O<sub>2</sub> Exposed Rats (Parts-II).
- Published in:
- Kufa Journal for Veterinary Medical Sciences, 2022, v. 13, n. 2, p. 42
- By:
- Publication type:
- Article
Synthesis of Novel Functionalized Pyrano Annulated/Oxazolone Pendent Chromone Derivatives as Potent Anti-Diabetic Agents.
- Published in:
- Russian Journal of General Chemistry, 2020, v. 90, n. 6, p. 1074, doi. 10.1134/S1070363220060225
- By:
- Publication type:
- Article
Canagliflozin or acarbose versus placebo to ameliorate post‐bariatric hypoglycaemia – The HypoBar I randomized clinical trial protocol.
- Published in:
- Diabetic Medicine, 2024, v. 41, n. 6, p. 1, doi. 10.1111/dme.15320
- By:
- Publication type:
- Article
Different clinical prognostic factors are associated with improved glycaemic control: findings from MARCH randomized trial.
- Published in:
- Diabetic Medicine, 2017, v. 34, n. 4, p. 490, doi. 10.1111/dme.13154
- By:
- Publication type:
- Article
Long-term use of acarbose and CV Event: confusing finding from mega data bank.
- Published in:
- Diabetic Medicine, 2016, v. 33, n. 12, p. 1749, doi. 10.1111/dme.13147
- By:
- Publication type:
- Article
Reply to 'Long-term use of acarbose and CV event: confusing finding from mega data bank'.
- Published in:
- Diabetic Medicine, 2016, v. 33, n. 12, p. 1750, doi. 10.1111/dme.13145
- By:
- Publication type:
- Article
Guidelines for managing diabetes in Ramadan.
- Published in:
- Diabetic Medicine, 2016, v. 33, n. 10, p. 1315, doi. 10.1111/dme.13080
- By:
- Publication type:
- Article
Use of the continuous glucose monitoring system to treat insulin autoimmune syndrome: quantification of glucose excursions and evaluation of treatment efficacy.
- Published in:
- Diabetic Medicine, 2014, v. 31, n. 7, p. e20, doi. 10.1111/dme.12418
- By:
- Publication type:
- Article
Low-dose acarbose does not delay digestion of starch but reduces its bioavailability.
- Published in:
- Diabetic Medicine, 2007, v. 24, n. 6, p. 600, doi. 10.1111/j.1464-5491.2007.02115.x
- By:
- Publication type:
- Article
Efficacy and safety of alogliptin versus acarbose in Chinese type 2 diabetes patients with high cardiovascular risk or coronary heart disease treated with aspirin and inadequately controlled with metformin monotherapy or drug‐naive: A multicentre, randomized, open‐label, prospective study (ACADEMIC)
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 6, p. 991, doi. 10.1111/dom.14661
- By:
- Publication type:
- Article
Postprandial hypoglycaemia after Roux‐en‐Y gastric bypass and the effects of acarbose, sitagliptin, verapamil, liraglutide and pasireotide.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 9, p. 2142, doi. 10.1111/dom.13796
- By:
- Publication type:
- Article
Effect of race on the glycaemic response to sitagliptin: Insights from the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS).
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1427, doi. 10.1111/dom.13242
- By:
- Publication type:
- Article
Efficacy and safety of saxagliptin compared with acarbose in Chinese patients with type 2 diabetes mellitus uncontrolled on metformin monotherapy: Results of a Phase IV open-label randomized controlled study (the SMART study).
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 11, p. 1513, doi. 10.1111/dom.12942
- By:
- Publication type:
- Article
Acarbose and metabolic control in patients with type 2 diabetes with newly initiated insulin therapy.
- Published in:
- Diabetes, Obesity & Metabolism, 2007, v. 9, n. 6, p. 853, doi. 10.1111/j.1463-1326.2006.00666.x
- By:
- Publication type:
- Article
Reflecting on Type 2 Diabetes Prevention: More Questions than Answers!
- Published in:
- Diabetes, Obesity & Metabolism, 2007, v. 9, p. 3, doi. 10.1111/j.1463-1326.2007.00768.x
- By:
- Publication type:
- Article
Prevention of complications of diabetes Oral therapies for T2D.
- Published in:
- Practice Nurse, 2012, v. 42, n. 5, p. 14
- By:
- Publication type:
- Article
CONFERENCE SPOTLIGHT.
- Published in:
- 2017
- Publication type:
- Proceeding
CONFERENCE SPOTLIGHT.
- Published in:
- 2017
- Publication type:
- Conference Paper
DIABETES FOUNDATION. Diabetes Treatment: Oral Agents.
- Published in:
- Clinical Diabetes, 2010, v. 28, n. 3, p. 132, doi. 10.2337/diaclin.28.3.132
- By:
- Publication type:
- Article
Rosiglitazone Reduced the Incidence of Diabetes in Patients With Impaired Glucose Tolerance.
- Published in:
- Clinical Diabetes, 2007, v. 25, n. 1, p. 23, doi. 10.2337/diaclin.25.1.23
- By:
- Publication type:
- Article
Acarbose now available in 25-mg tablets.
- Published in:
- Clinical Diabetes, 1998, v. 16, n. 2, p. 88
- Publication type:
- Article
Acarbose Add-on Therapy in Patients with Type 2 Diabetes Mellitus with Metformin and Sitagliptin Failure: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study.
- Published in:
- Diabetes & Metabolism Journal, 2019, v. 43, n. 3, p. 287, doi. 10.4093/dmj.2018.0054
- By:
- Publication type:
- Article
Post-Marketing Surveillance of Acarbose Treatment in Patients with Type 2 Diabetes Mellitus and Subjects with Impaired Glucose Tolerance in China.
- Published in:
- Clinical Drug Investigation, 2007, v. 27, n. 6, p. 397, doi. 10.2165/00044011-200727060-00003
- By:
- Publication type:
- Article
Postmarketing Surveillance of Acarbose Treatment in Taiwanese Patients with Type 2 Diabetes Mellitus.
- Published in:
- Clinical Drug Investigation, 2006, v. 26, n. 10, p. 559, doi. 10.2165/00044011-200626100-00002
- By:
- Publication type:
- Article
Evaluation of the Efficacy and Tolerability of Acarbose in Patients with Diabetes Mellitus: A Postmarketing Surveillance Study.
- Published in:
- Clinical Drug Investigation, 2005, v. 25, n. 10, p. 651, doi. 10.2165/00044011-200525100-00004
- By:
- Publication type:
- Article
Safety and Tolerability of Acarbose in the Treatment of Type 1 and Type 2 Diabetes Mellitus.
- Published in:
- Clinical Drug Investigation, 2005, v. 25, n. 9, p. 579, doi. 10.2165/00044011-200525090-00003
- By:
- Publication type:
- Article
Long-Term Efficacy and Tolerability of Acarbose Treatment in Patients with Type 2 Diabetes Mellitus.
- Published in:
- Clinical Drug Investigation, 2005, v. 25, n. 9, p. 589, doi. 10.2165/00044011-200525090-00004
- By:
- Publication type:
- Article
Long-Term Improvement of Metabolic Control by Acarbose in Type 2 Diabetes Patients Poorly Controlled with Maximum Sulfonylurea Therapy.
- Published in:
- Clinical Drug Investigation, 2003, v. 23, n. 10, p. 679, doi. 10.2165/00044011-200323100-00007
- By:
- Publication type:
- Article
Effect of Add-On Acarbose to Insulin Therapy in Routine Clinical Practice.
- Published in:
- Clinical Drug Investigation, 2003, v. 23, n. 10, p. 621, doi. 10.2165/00044011-200323100-00001
- By:
- Publication type:
- Article
Acarbose: An Update of Its Therapeutic Use in Diabetes Treatment.
- Published in:
- Clinical Drug Investigation, 2002, v. 22, n. 3, p. 141
- By:
- Publication type:
- Article
Characterization of a Digestive α-Amylase in the Midgut of Pieris brassicae L. (Lepidoptera: Pieridae).
- Published in:
- Frontiers in Physiology, 2016, p. 1, doi. 10.3389/fphys.2016.00096
- By:
- Publication type:
- Article
The use of oral hypoglycaemic agents in gestational diabetes.
- Published in:
- African Journal of Diabetes Medicine, 2015, v. 13, n. 1, p. 5
- By:
- Publication type:
- Article
Association of Acarbose with Decreased Muscle Mass and Function in Patients with Type 2 Diabetes: A Retrospective, Cross-Sectional Study.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 11, p. 2955, doi. 10.1007/s13300-021-01151-6
- By:
- Publication type:
- Article
Diabetic Gastroparesis.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 5, p. 1723, doi. 10.1007/s13300-018-0475-4
- By:
- Publication type:
- Article
Pentadecanoic Acid (C15:0), an Essential Fatty Acid, Shares Clinically Relevant Cell-Based Activities with Leading Longevity-Enhancing Compounds.
- Published in:
- Nutrients, 2023, v. 15, n. 21, p. 4607, doi. 10.3390/nu15214607
- By:
- Publication type:
- Article
Habitual Dietary Intake Affects the Altered Pattern of Gut Microbiome by Acarbose in Patients with Type 2 Diabetes.
- Published in:
- Nutrients, 2021, v. 13, n. 6, p. 2107, doi. 10.3390/nu13062107
- By:
- Publication type:
- Article
Antidiabetic Effects of a Short Peptide of Potato Protein Hydrolysate in STZ-Induced Diabetic Mice.
- Published in:
- Nutrients, 2019, v. 11, n. 4, p. 779, doi. 10.3390/nu11040779
- By:
- Publication type:
- Article
Acarbose Treatment and the Risk of Cardiovascular Disease and Hypertension in Patients With Impaired Glucose Tolerance: The STOP-NIDDM Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2003, v. 290, n. 4, p. 486, doi. 10.1001/jama.290.4.486
- By:
- Publication type:
- Article
The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial.
- Published in:
- 1994
- By:
- Publication type:
- journal article
A novel mutation in the ABCC8 gene causing maturity-onset diabetes of the young: A case report.
- Published in:
- Clinical Medicine, 2024, v. 24, n. 2, p. 1, doi. 10.1016/j.clinme.2024.100033
- By:
- Publication type:
- Article